Previous Article | Next Article 
Infect Immun, January 1998, p. 140-144, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Binding of Candida albicans to
Immobilized Amino Acids and Bovine Serum Albumin
Stephen P.
Hawser
and
Khalid
Islam*
Lepetit Research Center, 21040 Gerenzano
(VA), Italy
Received 16 June 1997/Returned for modification 5 August
1997/Accepted 10 October 1997
 |
ABSTRACT |
In this study, we examined the binding of Candida
albicans synchronized yeast-phase cells to plastic, immobilized
amino acids and bovine serum albumin (BSA) and quantified the binding
by using an XTT tetrazolium salt assay and absorbance determination.
Our results show that C. albicans binds efficiently and
specifically to several nonpolar aliphatic amino acids and positively
charged amino acids and to BSA immobilized on tissue culture plastic
but not to polar uncharged, negatively charged, or aromatic amino acids. Adhesion of yeasts to immobilized amino acids was not affected by preincubation of cells with BSA, whereas binding to immobilized BSA
was affected by preincubation of yeasts with alanine, proline, and
leucine but not by arginine or lysine. The ability to distinguish the
chirality of these amino acids was also examined by using both the
D and L amino acid configurations, and the
results show that C. albicans yeasts recognize only the
L configuration of these amino acids. The observations that
C. albicans specifically binds to certain amino acids
indicate that these amino acids may prove useful tools for studying the
binding interactions of C. albicans yeasts with host
proteins such as components of the extracellular matrix.
 |
INTRODUCTION |
Candida albicans is a
prevalent and troublesome opportunistic yeast which can cause a variety
of superficial and disseminated deep-seated mycoses (3, 20).
The most serious complications of the disease are the development of
the disseminated infections, resulting in endocarditis, nephritis, and
endophthalmitis. The ability of Candida to attach to
different types of host surfaces is currently undergoing extensive
investigation as a potential new area for therapy (16) and
is considered to be one of the initial steps in the pathogenesis of the
organism (9, 18). For example, Candida has been
shown to adhere to a variety of different surfaces, including plastic
and epithelial and endothelial cells, and to the extracellular matrix
proteins fibronectin, type IV collagen, laminin, and entactin (6,
9, 14, 15, 18, 21), of which the adhesion process is highly
dependent on the nature of the Candida cell surface and that
of the substratum (2, 9, 18). Furthermore, several
postadhesion events, such as the synthesis of new Candida
surface proteins and tyrosine phosphorylation of a number of proteins
(1) and phagocytosis and damage of endothelial cells by
C. albicans (5), can occur.
Several adhesion studies employing antibody, radiolabelling, or
microbiological assays have demonstrated the binding of C. albicans to plastic, to human serum proteins such as albumin and transferrin, and to several extracellular matrix proteins (2, 9,
10-12, 19). The influence of Arg-Gly-Asp (RGD)-containing peptides on the binding of C. albicans to extracellular
components has also been examined (9). In this study, we
used XTT tetrazolium salt, which is reduced to the blue-black formazan
product by metabolically active cells, and a 96-well microtiter format
to study the adhesion of C. albicans to plastic or
substrate-coated surfaces. We show that C. albicans yeasts
can bind specifically to immobilized bovine serum albumin (BSA) and to
certain immobilized amino acids and that the binding of yeasts to amino
acids is stereospecific.
 |
MATERIALS AND METHODS |
Chemicals, organisms, and reagents.
Type B gelatin from
bovine skin, type IV BSA, phenazine methosulfate (PMS), and
2,3-bis(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide inner salt (XTT) tetrazolium salt were purchased from Sigma Chemical Co. (St. Louis, Mo.). Amino acids of D and L
configurations were purchased from Calbiochem (La Jolla, Calif.).
C. albicans CA6406, CA444, and CA74 were kindly provided by
D. Kerridge (Cambridge, England), J.-P. Latgé (Pasteur Institut,
Paris, France), and M. Monod (Lausanne, Switzerland), respectively.
Culture conditions.
C. albicans ATCC 10231, CA6406,
CA444, CA74, and SKF 2270 were grown as synchronized yeasts and
prepared for use in binding experiments as described previously
(7). Briefly, to obtain synchronized stationary yeast-phase
cultures, freeze-dried stock cultures were resuspended in 0.1 M
phosphate-buffered saline (PBS; pH 7.2), inoculated into Minimal-40
medium (Difco Laboratories, Detroit, Mich.) at 105
cells/ml, and incubated at 25°C for 48 h without agitation. This synchronous cell yield was 1 × 108 to 2 × 108. Cells were then harvested, washed three times in 0.1 M
PBS, and used immediately.
Binding assay.
One hundred microliters of either BSA (1 mg/ml) or appropriate amino acid (1 mg/ml) in 0.15 M PBS (pH 7.38), or
PBS only, was added to wells of 96-well Greiner microtiter plates,
which were incubated for 1 to 2 h at room temperature. At the end
of the incubation period, the solution was removed from the wells and
the remaining sites were blocked with a 1% (wt/vol) solution of
gelatin for 1 h at room temperature. Thereafter, the wells were
challenged with a 100-µl solution of PBS containing 105
C. albicans yeasts/ml. The plates were incubated on an
orbital shaker at 100 rpm for 1 h at room temperature, after which
time the wells were washed vigorously three times with PBS to remove nonadherent yeasts. Thereafter, adhesion of yeasts to wells was determined by using a modification of the XTT assay described by
Tellier et al. (22), used to assess the activities of
antifungal agents against planktonic C. albicans yeasts, as
follows. Prior to each adhesion assay, XTT (1 g/liter of Ringer's
lactate) was thawed, and 40 µl of phenazine methosulfate stock
solution (1.53 mg/ml of PBS) was added to 8 ml of XTT. Thereafter, 100 µl of the XTT-phenazine methosulfate solution was added to wells, the wells were incubated for up to 3.5 h at 35°C, and the absorbance of wells was measured at 492 nm, using a Titertek microtiter plate reader.
For competition experiments, 105 yeasts were preincubated,
with agitation, for 1 h in 1 ml of a 1-mg/ml solution of the
appropriate amino acid or BSA. Where indicated for
concentration-dependent experiments, yeasts were preincubated with
various concentrations of BSA ranging between 0.001 and 10 mg/ml. Free
amino acid or BSA was subsequently removed by centrifugation and
washing three times with PBS prior to challenging immobilized amino
acid or BSA. Thereafter, adhesion of yeasts was quantified by the XTT tetrazolium salt assay described above.
Microscopy.
The numbers of yeasts bound to different
substrates were also quantified in an Olympus (1×70) inverted
microscope. Ten randomized fields of 360,000 µm2 per well
were counted and normalized to the total surface area of the microtiter
well. At least three to four wells were counted for each substrate
binding experiment.
Statistical analysis.
Comparisons of data from binding
experiments were carried out by Student's t test, using the
StatWorks program. Significant differences between data were expressed
at P < 0.01, P < 0.05, or
P < 0.001.
 |
RESULTS |
Binding of yeasts to plastic or protein-coated surfaces.
The
ability of yeasts from five different C. albicans strains to
bind to uncoated (plastic) or protein-coated surfaces was examined.
After removal of nonadherent yeasts by washing with PBS, the yeasts
which remained bound to the uncoated (plastic) or surfaces coated with
BSA or gelatin were examined by light microscopy. No morphological
differences were detected between the adherent and the nonadherent
populations; all cells showed the typical blastospore morphology. The
number of yeasts which bound to the plastic surface represented up to
50% of the initial added inoculum. Five C. albicans
strains, including the four clinical isolates CA74, CA4444, CA6406, and
SKF 2270, were used in these preliminary studies. All strains exhibited
very similar behaviors, and consequently strain ATCC 10231 was chosen
for all further studies.
The binding of yeasts to plastic, BSA, and gelatin was also quantified.
The adherent cells were counted in at least three
to four wells for
each condition, using light microscopy and viewing
a surface area of
360,000 µm
2 (see Materials and Methods). As shown in Fig.
1A, there was good
binding to both
plastic and BSA but minimal binding to gelatin.
Similar results were
obtained when the XTT tetrazolium salt procedure
was used in that a
large increase in absorbance was observed in
the uncoated (plastic) or
BSA-coated wells but absorbance in the
gelatin-coated wells was similar
to that in wells which had not
been challenged with yeasts (Fig.
1).
For example, cell counting
suggests that levels of binding to BSA and
gelatin were about
54 and 4%, respectively, compared with the binding
of yeasts to
plastic. The XTT procedure gave similar results whereby
the levels
of binding of yeasts to BSA and gelatin were about 65 and
2%,
respectively, compared with the binding of yeasts to plastic.
Untreated yeasts or yeasts preincubated with a 1% (wt/vol) solution
of
gelatin prior to challenging the uncoated (plastic) wells yielded
similar results in that both untreated and treated yeasts bound
efficiently to plastic and high absorbance at 492 nm was observed.
These data suggest that under these conditions,
C. albicans
yeasts
do not bind gelatin. These results suggest that the XTT
tetrazolium
salt procedure provides a useful means for the
quantification
of yeast cells. This procedure was therefore used in all
further
experiments to quantify binding of yeasts to different
substrates
by determination of absorbance at 492 nm.

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 1.
(A) Binding of yeasts to plastic, BSA, or gelatin
quantified by light microscopy (see Materials and Methods). The bars
represent the means (n = 4) ± standard deviations from
a typical experiment. (B) Quantification of yeasts bound to plastic,
BSA, or gelatin by the XTT tetrazolium salt procedure. XTT formazan was
measured after 3.5 h of incubation, and the bars represent the
means ± standard deviations (n = 21).
|
|
Binding of yeasts to immobilized BSA and influence of pretreatment
with BSA.
The inability of yeasts to bind to immobilized gelatin
suggested that this protein can be used as a blocking agent and thus provides a useful means to study the specific interaction of yeast cells with different substrates. The interaction of yeast cells with
BSA was therefore examined by immobilizing BSA in wells and by blocking
remaining sites with gelatin prior to challenge with yeast cells. The
presence of gelatin did not affect the ability of yeast cells to bind
to immobilized BSA (Fig. 2A). Similar
treatment with BSA significantly (P < 0.001) abolished
the ability of the yeast cells to bind to immobilized BSA (Fig. 2A) and
was concentration dependent; i.e., binding of yeast cells to
immobilized BSA was significantly reduced (P < 0.001)
when yeasts were preincubated with either 1 or 10 mg of BSA per ml
(Fig. 2B). Preincubation of yeasts followed by removal of BSA in
solution further showed that the binding to immobilized BSA was
attenuated (P < 0.001), indicating the specific
interaction of the yeast cells with the immobilized substrate (Fig.
2B).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 2.
Binding of yeast cells to immobilized BSA. (A) Binding
of yeast cells to BSA (BSA), effects of preincubation with BSA on
binding of yeast cells to immobilized BSA (BSA/BSA) and following
washout of free BSA [BSA(wash)/BSA], and effects of preincubation
with gelatin on the binding of yeast cells to immobilized BSA
(PreGel-BSA). (B) Effects of preincubation of yeast cells with 0.001 to
10 mg of BSA per ml on binding of yeast cells to immobilized BSA (BSA
pretreatment followed by removal of free BSA in solution or BSA
treatment only). Data points represent the means ± standard
deviation (n = 20) of yeast cell binding from a typical
experiment.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
FIG. 3.
Measurements of the binding of yeast cells to
L and D configurations of immobilized alanine
(ALA), arginine (ARG), leucine (LEU), lysine (LYS), and proline (PRO).
The bars represent the means ± standard deviations
(n = 20) of yeast cell binding from a typical
experiment.
|
|
Binding of yeasts to immobilized amino acids.
The interactions
of yeast cells with immobilized amino acids was also examined. The
amino acids were coated onto microtiter plates (Materials and Methods),
and the nonspecific protein binding sites were blocked with a 1%
(wt/vol) solution of gelatin. After blocking with gelatin, the
immobilized amino acids were challenged with yeast cells, and after
removal of nonadherent yeasts by washing, the specific binding was
determined by using the XTT assay and measurements of absorbance at 492 nm. Of the natural amino acids tested, yeasts were able to bind
efficiently only to immobilized arginine, alanine, leucine, lysine, and
proline (Table 1). Typically, binding of
yeasts to these immobilized amino acids was similar to the binding of
yeast cells to immobilized BSA (Fig. 1 and 2). The binding of yeast
cells to the D configuration of these amino acids was also
determined, and as shown in Fig. 3, yeast
cells failed to show any significant binding (P < 0.001) to the D configuration of these amino acids.

View larger version (20K):
[in this window]
[in a new window]
|
FIG. 4.
Effects of preincubation of yeast cells with BSA on the
binding of yeast cells to immobilized alanine (ALA), arginine (ARG),
leucine (LEU), lysine (LYS), or proline (PRO). Data points represent
the means ± standard deviations (n = 20) of yeast
cell binding from a typical experiment.
|
|
In view of the observation that preincubation with BSA inhibits the
ability of yeast cells to bind to immobilized BSA (Fig.
2), we also
examined the effect of preincubation of yeasts with
BSA on the ability
of yeast cells to bind to immobilized
L-amino
acids. As
shown in Fig.
4, yeast cells bound equally well to immobilized
amino
acids in the presence or absence of BSA treatment, except
that
pretreatment with BSA resulted in a slight increase (
P <
0.05) in binding to
L-leucine (Fig.
4).
Specificity of binding of yeasts to immobilized amino acid or
BSA.
Considering the ability of yeast cells to bind to BSA or
amino acids, we examined the effects of preincubation with each amino acid on the ability of yeast cells to adhere to immobilized BSA. In
these experiments, BSA was immobilized in wells, yeasts were preincubated with 1 mg of appropriate amino acid per ml, and the immobilized BSA was challenged with the amino acid-pretreated yeast
cells. Preincubation of yeast cells with 1 mg of arginine or lysine per
ml did not attenuate the binding of yeast cells to immobilized BSA,
whereas preincubation with 1 mg of alanine, leucine, or proline per ml
attenuated the binding of yeast cells to immobilized BSA (Table
2).
To assess the specificity of the binding interaction between yeast
cells and each amino acid, we preincubated yeasts with
1 mg of each
amino acid per ml and then challenged wells containing
immobilized
amino acid with yeasts. Yeast cells preincubated with
the same amino
acid as that immobilized in wells showed dramatically
attenuated
binding to the immobilized amino acid and acted as
positive controls in
the experiment (for statistical analysis
and significance values, see
Table
2). The binding of yeast cells
to arginine was inhibited by
lysine but not by leucine, proline,
or alanine. Similarly, binding to
lysine was inhibited by arginine
but not by the other amino acids
(Table
2). The binding of yeasts
to immobilized alanine was inhibited
by lysine but not by the
other amino acids, whereas binding of yeasts
to proline was inhibited
by leucine and lysine but not by alanine and
arginine (Table
2).
By contrast, binding to leucine was affected by
alanine but not
by the other amino acids (Table
2).
 |
DISCUSSION |
Candida cells have been suggested to bind to a variety
of human proteins and gelatin (2, 7, 18). Our results show that C. albicans yeasts bind to plastic and BSA-coated
surfaces but fail to adhere to gelatin-coated surfaces. Quantification of adherent cells by light microscopy and use of XTT tetrazolium salt
yield similar results. The XTT tetrazolium salt procedure has several
important advantages over use of cell counting techniques in that (i)
the method is easy to use compared to the tedious counting by light
microscopy, (ii) it allows a rapid and quantitative measurement, and
(iii) only metabolically active cells are determined by this method.
Here we have shown that by using XTT tetrazolium salt, C. albicans yeasts bind efficiently to plastic, binding of yeasts to
plastic is abolished by blocking the surface with gelatin, and yeasts
bind to immobilized BSA and interestingly to several different amino
acids. Gelatin therefore provides a means to diminish nonspecific
binding to plastic surfaces such that the specific binding to
immobilized substrates such as amino acids, peptides, and proteins can
be determined.
Our data concerning gelatin do not appear to be in agreement with the
observations of Klotz and Smith (12), who suggested that
yeasts may bind to porcine gelatin. However, we have also used porcine
gelatin and have found that, as was the case for bovine gelatin, yeasts
do not bind to this substrate (8). The reasons for the
difference between our data and those of Klotz and Smith
(12) are unclear but may reflect differences in experimental procedures. For example, in this study we used synchronized yeast-phase cells which were prepared by growth in Minimal-40 medium and quantified binding of the yeasts to different substrates by using both light microscopy and the XTT tetrazolium salt procedure. In addition, the
assay conditions involve binding of yeasts (initial inoculum of
105 cells/ml) to different substrates at 25°C for 1 h with agitation, and the assay is performed in wells of 96-well
microtiter plates. Under these conditions using five C. albicans strains including four clinical isolates, we observed
that all of the strains showed similar behaviors in terms of the
ability to bind to plastic and BSA and the inability to bind to
gelatin. The conditions used in this study appear to be quite different
from those described elsewhere. Generally, most studies use lower
inocula and consequently examine the adherence of significantly fewer
cells. For example, Klotz and Smith (12) used about 250 cells per well in 24-well tissue culture plates, whereas we used 10,000 cells per well in 96-well tissue culture plates. The number of adherent
cells in the case of the plastic surface is normally about 5,000 in our study, compared with 200 cells in the case of the study by Klotz and
Smith (12). The assay conditions used by Klotz and Smith (12) involved yeasts which were previously cultured in
Sabouraud dextrose broth and binding of yeasts (initial inoculum of
103 cells/ml) at 37°C for 30 min without agitation
(12). Indeed, Klotz et al. (13) have previously
noted that there is no standardized method for measuring adherence,
making it difficult to compare results from different studies. Under
the conditions used, Klotz et al. (13) have shown the
presence of a fibronectin/gelatin binding protein which appears to be
present on the C. albicans cells. There are different
reports in the literature which demonstrate the presence of specific
epitopes under specific environmental conditions (4). It is
quite probable that culture conditions, inoculum size, time of contact,
temperature, and the surface area to which the yeast cells are applied
influence the ability of yeast cells to bind to immobilized substrates,
and one or more of these variations may account for the different
observations between this study and that described elsewhere
(12).
The binding of yeast cells to immobilized BSA was reduced by more than
90% when yeast cells were preincubated with BSA, binding was dependent
on the concentration of BSA used in preincubations, and removal of free
BSA in solution also showed attenuation of the binding of yeast cells
to immobilized BSA. These data, therefore, indicate that the yeast
cell-BSA interaction may be a specific process and that the affinity of
this interaction is high. Other studies have shown that several host
proteins, notably lactoferrin and ovotransferrin (23), and
complement fragments, such as C3d and iC3b (10), are known
to bind to C. albicans, and C. albicans germ
tubes bind human albumin with high avidity (17).
Binding studies with individual natural amino acids with C. albicans yeast cells demonstrated that yeast cells may bind to specific nonpolar aliphatic amino acids, namely, alanine, leucine, and
proline, and the positively charged R-group amino acids arginine and
lysine. By contrast, yeast cells were unable to bind to amino acids
from polar uncharged, aromatic, or negatively charged amino acids.
Interestingly, yeast cells were not able to bind to other nonpolar
aliphatic amino acids such as glycine, valine, and isoleucine or to the
positively charged histidine, which suggests a degree of specificity in
the binding of yeast cells to amino acids from nonpolar aliphatic and
positively charged groups. Moreover, unlike the binding of yeast cells
to the L configuration of alanine, arginine, leucine,
lysine, or proline, yeast cells were unable to bind the D
configuration of these amino acids, further indicating that the yeast
cell-amino acid binding interactions are specific and demonstrate
stereospecificity. Furthermore, competitive binding studies showed that
preincubation with each amino acid inhibited the interaction with
itself when immobilized on wells.
To the best of our knowledge, this is the first report of the binding
of C. albicans to immobilized amino acids. By contrast, other studies have concentrated on interactions of Candida
yeasts or germ tubes with components of the extracellular matrix such as fibronectin, laminin, and collagen and the potential of different peptides, including those with an RGD sequence, on this interaction (9). Furthermore, the binding of Candida yeasts
to large proteins such as BSA is likely to involve particular amino
acids. Therefore, it would have been expected that pretreatment of
yeast cells with BSA would inhibit the binding interaction of yeast
cells to immobilized amino acids. However, binding of BSA-treated yeast
cells to amino acids was similar to the binding of untreated, control
yeast cells, indicating that pretreatment with BSA does not affect the
binding interaction of yeast cells with immobilized amino acids. On the other hand, preincubation of yeast cells with the nonpolar aliphatic amino acids attenuated the binding of yeast cells to immobilized BSA by
25 to 55%, while preincubation with arginine or lysine did not affect
the binding interaction between yeast cells and immobilized BSA. In
large proteins such as BSA, one may expect a number of potential sites
for binding whereby the binding interaction with the sites may be of a
cooperative nature. Therefore, the effect of each amino acid on the
binding of yeast cells to immobilized BSA may not necessarily cause a
complete attenuation of binding. Indeed, the slight reduction in the
ability of yeast cells treated with alanine, leucine, or proline to
bind to immobilized BSA may indicate that such amino acids are involved
in the interaction of BSA with C. albicans yeast cells.
As regards the binding of yeast cells to immobilized amino acids,
lysine effectively blocked the binding of yeasts to immobilized arginine and vice versa, as would be expected for similarly charged amino acids, suggesting the presence of similar binding sites for
arginine and lysine. On the other hand, the interaction of yeast cells
with immobilized proline was also competed for by lysine and leucine
but not by alanine or arginine, and proline did not markedly attenuate
the binding interaction with immobilized alanine, arginine, leucine, or
lysine. These data suggest that the proline binds to sites which
partially overlap with sites for leucine and lysine but with a lower
affinity, whereas binding sites for leucine and alanine may partially
overlap with the binding sites for lysine and arginine or may be
sterically hindered by the binding of lysine or arginine. Moreover, all
of the nonpolar aliphatic amino acids, including proline, in fact
inhibit the binding of yeast cells to immobilized BSA, an effect which
is not seen with arginine or lysine.
Given that C. albicans yeast cells bind avidly to certain
amino acids, it may prove fruitful to use these findings as tools for
future research into the characteristics of the binding of yeast cells
to different substrates. Indeed, we are currently using this
information to study the specific interactions of C. albicans yeast cells with, for example, components of the
extracellular matrix.
 |
FOOTNOTES |
*
Corresponding author. Present address: Roussel Uclaf,
Hoechst Marion Roussel, 102 Route de Noisy, 93235 Romainville Cedex, France. Phone: 33-1-4991-3259. Fax: 33-1-4991-3116. E-mail:
KHALID.ISLAM{at}hmrag.com.
Present address: Roussel Uclaf, Hoechst Marion Roussel, 93235 Romainville Cedex, France.
Editor: T. R. Kozel
 |
REFERENCES |
| 1.
|
Bailey, A.,
E. Wadsworth, and R. Calderone.
1995.
Adherence of Candida albicans to human buccal epithelial cells: host-induced protein synthesis and signaling events.
Infect. Immun.
63:569-572[Abstract].
|
| 2.
|
Calderone, R. A., and P. C. Braun.
1991.
Adherence and receptor relationships of Candida albicans.
Microbiol. Rev.
55:1-20[Abstract/Free Full Text].
|
| 3.
|
Emori, T. G., and R. P. Gaynes.
1993.
An overview of nosocomial infections, including the role of the microbiology laboratory.
Clin. Microbiol. Rev.
6:428-442[Abstract/Free Full Text].
|
| 4.
|
Douglas, L. J.
1995.
Adhesin-receptor interactions in the attachment of Candida albicans to host epithelial cells.
Can. J. Bot.
73:S1147-S1153.
|
| 5.
|
Filler, S. G.,
J. N. Swerdloff,
C. Hobbs, and P. M. Luckett.
1995.
Penetration and damage of endothelial cells by Candida albicans.
Infect. Immun.
63:976-983[Abstract].
|
| 6.
|
Hawser, S. P., and L. J. Douglas.
1994.
Biofilm formation by Candida species on the surface of catheter materials in vitro.
Infect. Immun.
62:915-921[Abstract/Free Full Text].
|
| 7.
|
Hawser, S. P., and K. Islam.
1996.
Spectrophotometric determination of the morphogenetic transformation by synchronous Candida albicans: effects of antifungal agents.
J. Antimicrob. Chemother.
38:67-73[Abstract/Free Full Text].
|
| 8.
| Hawser, S. P., and K. Islam. Unpublished
results.
|
| 9.
|
Hostetter, M. K.
1994.
Adhesins and ligands involved in the interaction of Candida spp. with epithelial and endothelial surfaces.
Clin. Microbiol. Rev.
7:29-42[Abstract/Free Full Text].
|
| 10.
|
Hostetter, M. K.
1996.
An integrin-like protein in Candida albicans: implications for pathogenesis.
Trends Microbiol.
4:242-246[Medline].
|
| 11.
|
Klotz, S. A.
1990.
Adherence of Candida albicans to components of the subendothelial extracellular matrix.
FEMS Microbiol. Lett.
68:249-254.
|
| 12.
|
Klotz, S. A., and R. L. Smith.
1995.
Gelatin fragments block adherence of Candida albicans to extracellular matrix proteins.
Microbiology
141:2681-2684[Abstract/Free Full Text].
|
| 13.
|
Klotz, S. A.,
M. J. Rutten,
R. L. Smith,
S. R. Babcock, and M. D. Cunningham.
1993.
Adherence of Candida albicans to immobilized extracellular matrix proteins is mediated by calcium-dependent surface glycoproteins.
Microb. Pathog.
14:133-147[Medline].
|
| 14.
|
Lopez-Ribot, J. L., and W. L. Chaffin.
1994.
Binding of the extracellular matrix component entactin to Candida albicans.
Infect. Immun.
62:4564-4571[Abstract/Free Full Text].
|
| 15.
|
Negre, E.,
T. Vogel,
A. Levanon,
R. Guy,
T. J. Walsh, and D. D. Roberts.
1994.
The collagen binding domain of fibronectin contains a high affinity binding site for Candida albicans.
J. Biol. Chem.
269:22039-22045[Abstract/Free Full Text].
|
| 16.
|
Ofek, I.,
I. Kahane, and N. Sharon.
1996.
Toward anti-adhesion therapy for microbial diseases.
Trends Microbiol.
4:297-299[Medline].
|
| 17.
|
Page, S., and F. C. Odds.
1988.
Binding of plasma proteins to Candida species in vitro.
J. Gen. Microbiol.
134:2693-2702[Abstract/Free Full Text].
|
| 18.
|
Pendrak, M. L., and S. A. Klotz.
1995.
Adherence of Candida albicans to host cells.
FEMS Microbiol. Lett.
129:103-114[Medline].
|
| 19.
|
Penn, C., and S. A. Klotz.
1994.
Binding of plasma fibronectin to Candida albicans occurs through the cell binding domain.
Microb. Pathog.
17:387-393[Medline].
|
| 20.
|
Pittet, D., and R. P. Wenzel.
1995.
Nosocomial bloodstream infections. Secular trends in rates, mortality, and contribution to total hospital deaths.
Arch. Intern. Med.
155:1177-1184[Abstract/Free Full Text].
|
| 21.
|
San Millan, R.,
P. A. Ezkurra,
G. Quindos,
R. Robert,
J. M. Senet, and J. Ponton.
1996.
Effect of monoclonal antibodies directed against Candida albicans cell wall antigens of the fungus to polystyrene.
Microbiology
142:2271-2277[Abstract/Free Full Text].
|
| 22.
|
Tellier, R.,
M. Krajden,
G. A. Grigoriew, and I. Campbell.
1992.
Innovative endpoint determination system for antifungal susceptibility testing of yeasts.
Antimicrob. Agents Chemother.
36:1619-1625[Abstract/Free Full Text].
|
| 23.
|
Valenti, P.,
P. Visca,
G. Antonini, and N. Orsi.
1986.
Interaction between lactoferrin and ovotransferrin and Candida cells.
FEMS Microbiol. Lett.
33:271-275.
|
Infect Immun, January 1998, p. 140-144, Vol. 66, No. 1
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Becker, K., Almasri, A. S., von Eiff, C., Peters, G., Heilmann, C., Fegeler, W.
(2007). Systematic Survey of Nonspecific Agglutination by Candida spp. in Latex Assays. J. Clin. Microbiol.
45: 1315-1318
[Abstract]
[Full Text]
-
Klotz, S. A., Gaur, N. K., Lake, D. F., Chan, V., Rauceo, J., Lipke, P. N.
(2004). Degenerate Peptide Recognition by Candida albicans Adhesins Als5p and Als1p. Infect. Immun.
72: 2029-2034
[Abstract]
[Full Text]
-
Kuhn, D. M., Balkis, M., Chandra, J., Mukherjee, P. K., Ghannoum, M. A.
(2003). Uses and Limitations of the XTT Assay in Studies of Candida Growth and Metabolism. J. Clin. Microbiol.
41: 506-508
[Abstract]
[Full Text]
-
Kuhn, D. M., Chandra, J., Mukherjee, P. K., Ghannoum, M. A.
(2002). Comparison of Biofilms Formed by Candidaalbicans and Candidaparapsilosis on Bioprosthetic Surfaces. Infect. Immun.
70: 878-888
[Abstract]
[Full Text]
-
Islam, K., Hawser, S. P.
(1999). Effect of antifungal agents on the binding of Candida albicans to immobilized amino acids and bovine serum albumin. J Antimicrob Chemother
43: 583-587
[Abstract]
[Full Text]